Endothelin converting enzyme inhibitors

Details Endothelin converting enzyme inhibitors Endothelin converting enzyme inhibitors

C - Chemistry, Metallurgy

07

K

C07K 5/083 (2006.01) A61K 38/05 (2006.01) A61K 38/06 (2006.01) C07K 5/02 (2006.01) C07K 5/027 (2006.01) C07K 5/06 (2006.01) C07K 5/062 (2006.01) C07K 5/065 (2006.01) C07K 5/093 (2006.01) C07K 7/02 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2100171

2100171 9213545 PCTABS00014 Compounds are disclosed which inhibit endothelin converting enzyme. These compounds are useful for treating hypertension, congestive heart failure, myocardial infarction, reperfusion injury, coronary angina, cerebral vasospasm, acute renal failure, non-steroidal antiinflammatory drug induced gastric ulceration, cyclosporin induced nephrotoxicity, endotoxin-induced toxicity, asthma and atherosclerosis.

Affiliated with

Also associated with

Rating

Endothelin converting enzyme inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Endothelin converting enzyme inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endothelin converting enzyme inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2067235